|FOR IMMEDIATE RELEASE||
Chris Tofalli Public Relations, LLC
+1 914 834 4334
NEW YORK, June 4, 2007- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market healthcare and specialty manufacturing and services companies, today announced the sale of substantially all of the assets and liabilities of its portfolio company Renaissance Mark, Inc., one of the largest North American providers of prime labels and brand imaging solutions to the packaging industry, to Fort Dearborn Company. Terms of the transaction were not disclosed.
Renaissance Mark has four operating divisions in North America (Bowling Green, KY; Sparks, NV; Leamington, Ontario; and Montreal, Quebec), with approximately 660 employees. Arsenal acquired Renaissance Mark in 2002 from Cenveo, Inc. and under the firm's ownership the company has become a more customer focused organization, increased its depth of experience and recruited outstanding talent to continue its drive for excellence.
Stan Bikulege, Chief Executive Officer of Renaissance Mark, said, "The combination of Renaissance Mark and Fort Dearborn produces the premier label company in North America. Joining these two strong companies answers many of the needs of our outstanding group of customers. Fort Dearborn is a world class organization and we are excited about partnering with them."
Arsenal also announced that following Mr. Bikulege's successful tenure as CEO of Renaissance Mark, he will join Arsenal as an Executive Vice President. "Since November 2005, Stan demonstrated an ability to drive strong revenue growth and profit improvements at Renaissance Mark and, with the completion of the sale, we are very pleased that Stan will be joining Arsenal," said Mr. Mullen. "He will play an active role in the general management and oversight of some of Arsenal's portfolio companies and will also focus on sourcing new investments.
Arsenal Capital Partners is a New York-based private equity firm that makes control investments in specialty manufacturing and service companies. Arsenal makes investments in sectors where they have prior knowledge and experience, and targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm's infrastructure-focused operating team to improve businesses. Arsenal targets growing, niche market leading companies in the specialty manufacturing & services, specialty materials, specialty chemicals, aerospace & defense, and healthcare industries. The firm currently has $800 million of committed equity capital. For additional information on Arsenal Capital Partners please visit www.arsenalcapital.com.